 Eligible patients will be randomized in a 1:1:1 ratio to one of the three treatments Test, Reference or Placebo on Visit 1. Patients will be instructed to apply the first treatment on the evening of enrollment into the study and then continue to apply once daily for the next 83 days for a total 84 days. Patients will attend the following scheduled clinic visits: 